Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 2885364)

Published in BMC Cancer on May 26, 2010

Authors

William N Rom1, Judith D Goldberg, Doreen Addrizzo-Harris, Heather N Watson, Michael Khilkin, Alissa K Greenberg, David P Naidich, Bernard Crawford, Ellen Eylers, Daorong Liu, Eng M Tan

Author Affiliations

1: Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Radiology, Thoracic Surgery, and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA. william.rom@nyumc.org

Articles citing this

A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med (2013) 1.69

The grand challenge to decipher the cancer proteome. Nat Rev Cancer (2010) 1.49

Development of a multiplex autoantibody test for detection of lung cancer. PLoS One (2014) 0.91

Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma. J Proteome Res (2013) 0.89

Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts. PLoS One (2014) 0.86

Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD. Mol Genet Genomics (2012) 0.83

Current readings: blood-based biomarkers for lung cancer. Semin Thorac Cardiovasc Surg (2013) 0.81

IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype. Cell Death Dis (2015) 0.79

Asthma-predictive genetic markers in gene expression profiling of peripheral blood mononuclear cells. Allergy Asthma Immunol Res (2011) 0.78

Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag. Genes Cancer (2016) 0.75

Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer. Oncoimmunology (2017) 0.75

Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. PLoS One (2017) 0.75

Articles cited by this

Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med (2006) 19.06

Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (1999) 13.67

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06

New paths in human cancer serology. J Exp Med (1998) 3.12

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer (1982) 2.98

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci U S A (1996) 2.52

A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med (1999) 2.36

Clinical practice. Lung cancer screening. N Engl J Med (2005) 2.19

Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 2.14

Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene (2002) 1.95

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol (1999) 1.91

The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol (1992) 1.91

Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci U S A (2003) 1.86

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A (2001) 1.85

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. J Clin Oncol (1997) 1.84

Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest (2001) 1.81

Focal ground-glass opacity detected by low-dose helical CT. Chest (2002) 1.79

Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies. Clin Immunol (2001) 1.78

Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol (2006) 1.75

Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax (2007) 1.73

Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res (2003) 1.72

Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res (2002) 1.67

Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest (1993) 1.66

Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol (2008) 1.55

Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res (2003) 1.34

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res (1996) 1.29

Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer (2005) 1.28

Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res (2007) 1.26

Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res (2001) 1.24

Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Prostate (2005) 1.19

Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res (2005) 1.18

Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med (2005) 1.13

Immune response to cyclin B1 in hepatocellular carcinoma. Hepatology (1997) 1.09

Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer. Am J Respir Crit Care Med (2005) 1.09

Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Anticancer Res (2001) 1.04

Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. Int J Oncol (2005) 1.02

Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Lung Cancer (2004) 1.01

Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking. Lung Cancer (2003) 0.93

Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detect Prev (2003) 0.92

Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma. Int J Cancer (2002) 0.91

Circulating anti-p53 antibodies in lung cancer and relationship to histology and smoking. Biomarkers (1999) 0.82

Articles by these authors

Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology (2005) 9.83

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77

Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.69

Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.49

Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med (2010) 4.15

Prone vs supine positioning for breast cancer radiotherapy. JAMA (2012) 2.32

Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 2.14

Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med (2005) 2.11

Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol (2006) 2.11

Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. Am J Respir Crit Care Med (2013) 2.10

Survival in familial dysautonomia: Impact of early intervention. J Pediatr (2002) 1.98

Pulmonary nodules on multi-detector row CT scans: performance comparison of radiologists and computer-aided detection. Radiology (2004) 1.78

Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology (2009) 1.76

Small pulmonary nodules: volume measurement at chest CT--phantom study. Radiology (2003) 1.73

Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol (2004) 1.73

Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res (2003) 1.72

CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology (2004) 1.71

Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.68

Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) (2010) 1.68

Wavelet compression of low-dose chest CT data: effect on lung nodule detection. Radiology (2003) 1.58

Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. Clin Auton Res (2005) 1.52

Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2004) 1.51

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clin Cancer Res (2012) 1.46

SPECT in acute pulmonary embolism. J Nucl Med (2009) 1.40

Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics (2006) 1.32

Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol (2006) 1.29

Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer (2005) 1.28

Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum (2004) 1.26

Extraction of airways from CT (EXACT'09). IEEE Trans Med Imaging (2012) 1.25

Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn (2010) 1.23

Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol (2007) 1.23

Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol (2010) 1.20

CT of airways disease and bronchiectasis. Radiol Clin North Am (2002) 1.19

Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Prostate (2005) 1.19

Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17

Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett (2009) 1.16

Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2005) 1.13

PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13

Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res (2008) 1.13

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival. Breast Cancer Res Treat (2010) 1.12

CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort. PLoS One (2012) 1.12

Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III. Int J Cardiovasc Imaging (2011) 1.11

Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2012) 1.10

Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int J Radiat Oncol Biol Phys (2012) 1.10

A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest (2013) 1.09

Computer-aided diagnosis and the evaluation of lung disease. J Thorac Imaging (2004) 1.09

Overview and strategic management of subsolid pulmonary nodules. J Thorac Imaging (2012) 1.08

Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma. Int J Oncol (2005) 1.08

Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood (2002) 1.08

Use of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol (2011) 1.07

Computer-aided detection (CAD) of lung nodules in CT scans: radiologist performance and reading time with incremental CAD assistance. Eur Radiol (2009) 1.06

Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. Int J Oncol (2005) 1.02

Performance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer (2008) 1.02

Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma. Clin Cancer Res (2009) 1.01

Pulmonary Nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry. Radiology (2011) 1.01

Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing. Pediatr Res (2009) 1.00

Lung pathologic findings in a local residential and working community exposed to World Trade Center dust, gas, and fumes. J Occup Environ Med (2011) 0.99

Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood (2013) 0.99

Aryl hydrocarbon receptor and lung cancer. Anticancer Res (2013) 0.99

EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clin Cancer Res (2013) 0.99

Dual-energy computed tomography: concepts, performance, and thoracic applications. J Thorac Imaging (2012) 0.99

High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res (2010) 0.97

Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney Int (2004) 0.96

Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J Hepatol (2010) 0.96

Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework. Acad Med (2015) 0.96

Proactive approach to lymphedema risk reduction: a prospective study. Ann Surg Oncol (2014) 0.96

Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. Eur J Haematol (2007) 0.95

Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. Int J Radiat Oncol Biol Phys (2012) 0.95

Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detect Prev (2005) 0.94

A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm. Chest (2013) 0.94

PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition. Mol Cancer Res (2013) 0.94

A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF). Br J Haematol (2013) 0.94

Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. Int J Radiat Oncol Biol Phys (2011) 0.94

A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol (2003) 0.93

Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma. Anticancer Res (2010) 0.92

Pictorial essay: multinodular disease: a high-resolution CT scan diagnostic algorithm. Chest (2006) 0.92

Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2013) 0.90

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer. Breast Cancer Res (2014) 0.90

Dual-energy MDCT: comparison of pulmonary artery enhancement on dedicated CT pulmonary angiography, routine and low contrast volume studies. Eur J Radiol (2010) 0.90

Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2004) 0.90

Comparison of 1.5 and 3.0 T for contrast-enhanced pulmonary magnetic resonance angiography. Clin Appl Thromb Hemost (2011) 0.89

Identification of kinectin as a novel Behçet's disease autoantigen. Arthritis Res Ther (2005) 0.88

Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance induction. J Immunol (2009) 0.88

Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer. Am J Respir Cell Mol Biol (2002) 0.88

Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model. NMR Biomed (2011) 0.86

Boundary-specific cost functions for quantitative airway analysis. Med Image Comput Comput Assist Interv (2007) 0.84

Importance of MR technique for stereotactic radiosurgery. Neuro Oncol (2003) 0.84

Benefit of CT venography for the diagnosis of thromboembolic disease. Clin Imaging (2007) 0.84

Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms. Exp Hematol (2009) 0.84

Lung nodule detection and characterization with multislice CT. Radiol Clin North Am (2003) 0.84

S-adenosylmethionine as a biomarker for the early detection of lung cancer. Chest (2007) 0.84

Effect of blood vessels on measurement of nodule volume in a chest phantom. Radiology (2006) 0.84